I agree that this site is using cookies. You can find further informations here.
X
Lubking, Anna
31  results:
OpenAccess-fulltext X
?
1

The impact of Covid-19 in patients with chronic myeloid leu..:

Dahlen, Torsten ; Flygt, Hjalmar ; Lubking, Anna...
Leukemia, 0887-6924, 2023.  , 2023
Link: http://urn.kb.se/resolve..
 
?
2

The impact of Covid-19 in patients with chronic myeloid leu..:

Dahlén, Torsten ; Flygt, Hjalmar ; Lübking, Anna...
Leukemia, 0887-6924, 2023, 37, s. 1156-1159.  , 2023
Link: http://urn.kb.se/resolve..
 
?
3

The impact of Covid-19 in patients with chronic myeloid leu..:

Dahlén, Torsten ; Flygt, Hjalmar ; Lübking, Anna...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088575/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

IFN-α with dasatinib broadens the immune repertoire in pati..:

Huuhtanen, Jani ; Ilander, Mette ; Yadav, Bhagwan...
urn:issn:0021-9738.  , 2022
Link: https://hdl.handle.net/1..
 
?
5

IFN-α with dasatinib broadens the immune repertoire in pati..:

Huuhtanen, Jani ; Ilander, Mette ; Yadav, Bhagwan...
10.1172/JCI152585.  , 2022
Link: http://hdl.handle.net/10..
 
?
6

IFN-a with dasatinib broadens the immune repertoire in pati..:

Huuhtanen, Jani ; Ilander, Mette ; Yadav, Bhagwan...
Journal of Clinical Investigation, 0021-9738, 2022, 132:17,.  , 2022
Link: http://urn.kb.se/resolve..
 
?
7

IFN-α with dasatinib broadens the immune repertoire in pati..:

Huuhtanen, Jani ; Ilander, Mette ; Yadav, Bhagwan...
JOURNAL OF CLINICAL INVESTIGATION.  , 2022
Link: https://aaltodoc.aalto.f..
 
?
8

Molecular status 36 months after TKI discontinuation in CML..:

Richter, Johan ; Lubking, Anna ; Soderlund, Stina...
10.1038/s41375-021-01173-w.  , 2022
Link: http://hdl.handle.net/10..
 
?
9

IFN-alfa with dasatinib broadens the immune repertoire in p..:

Huuhtanen, Jani ; Ilander, Mette ; Yadav, Bhagwan...
Journal of Clinical Investigation, 0021-9738, 2022, 132:17,.  , 2022
Link: http://urn.kb.se/resolve..
 
?
10

Long-term tolerability and efficacy after initial PegIFN-al..:

Flygt, Hjalmar ; Söderlund, Stina ; Stentoft, Jesper...
10.1111/ejh.13699.  , 2022
Link: http://hdl.handle.net/10..
 
?
11

IFN-α with dasatinib broadens the immune repertoire in pati..:

Huuhtanen, Jani ; Ilander, Mette ; Yadav, Bhagwan...
Journal of Clinical Investigation. 2022, 132 (17), ..  , 2022
Link: https://hdl.handle.net/1..
 
?
12

Long-term tolerability and efficacy after initial PegIFN-α ..:

Flygt, Hjalmar ; Söderlund, Stina ; Stentoft, Jesper...
European Journal of Haematology, 0902-4441, 2021, 107:6, s. 617-623.  , 2021
Link: http://urn.kb.se/resolve..
 
?
13

Successful tyrosine kinase inhibitor discontinuation outsid..:

Flygt, Hjalmar ; Sandin, Fredrik ; Dahlen, Torsten...
British Journal of Haematology, 0007-1048, 2021, 193:5, s. 915-921.  , 2021
Link: http://urn.kb.se/resolve..
 
?
14

Molecular status 36 months after TKI discontinuation in CML..:

Richter, Johan ; Lubking, Anna ; Soderlund, Stina...
Leukemia, 0887-6924, 2021, 35, s. 2416-2418.  , 2021
Link: http://urn.kb.se/resolve..
 
?
15

Successful tyrosine kinase inhibitor discontinuation outsid..:

Flygt, Hjalmar ; Sandin, Fredrik ; Dahlén, Torsten...
British Journal of Haematology, 0007-1048, 2021, 193:5, s. 915-921.  , 2021
Link: http://urn.kb.se/resolve..
 
1-15